tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2020 Dec 22;7(12)
faa575.
doi: 10.1093/ofid/ofaa575. eCollection 2020 Dec.
Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
Deanna J Buehrle[SUP] 1 [/SUP], M Hong Nguyen[SUP] 2 [/SUP], Marilyn M Wagener[SUP] 2 [/SUP], Cornelius J Clancy[SUP] 2 [/SUP]
Affiliations
Abstract
In April 2020, there were significant reductions in prescription fills of each of the 10 most prescribed outpatient antibiotics in the United States. Monthly azithromycin, amoxicillin-clavulanate, and levofloxacin fills did not rebound significantly from April through July 2020. Coronavirus disease 2019 had an immediate and sustained impact on US outpatient antibiotic prescribing.
Keywords: COVID-19; United States; antibiotics; coronavirus disease 2019; outpatient; prescriptions.
. 2020 Dec 22;7(12)
faa575.doi: 10.1093/ofid/ofaa575. eCollection 2020 Dec.
Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
Deanna J Buehrle[SUP] 1 [/SUP], M Hong Nguyen[SUP] 2 [/SUP], Marilyn M Wagener[SUP] 2 [/SUP], Cornelius J Clancy[SUP] 2 [/SUP]
Affiliations
- PMID: 33409334
- PMCID: PMC7765437
- DOI: 10.1093/ofid/ofaa575
Abstract
In April 2020, there were significant reductions in prescription fills of each of the 10 most prescribed outpatient antibiotics in the United States. Monthly azithromycin, amoxicillin-clavulanate, and levofloxacin fills did not rebound significantly from April through July 2020. Coronavirus disease 2019 had an immediate and sustained impact on US outpatient antibiotic prescribing.
Keywords: COVID-19; United States; antibiotics; coronavirus disease 2019; outpatient; prescriptions.